Pathstone Holdings’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.27M Buy
26,832
+2,258
+9% +$116K ﹤0.01% 1383
2026
Q1
$1.46M Buy
24,574
+12,396
+102% +$804K 0.01% 1207
2025
Q4
$751K Sell
12,178
-7,583
-38% -$464K ﹤0.01% 1563
2025
Q3
$1.23M Buy
19,761
+1,765
+10% +$123K ﹤0.01% 1299
2025
Q2
$1.44M Sell
17,996
-11,478
-39% -$960K 0.01% 1192
2025
Q1
$2.53M Buy
29,474
+12,978
+79% +$1.06M 0.01% 849
2024
Q4
$1.29M Buy
16,496
+1,805
+12% +$140K 0.01% 1224
2024
Q3
$1.06M Buy
14,691
+5,123
+54% +$363K ﹤0.01% 1343
2024
Q2
$659K Buy
9,568
+17
+0.2% +$1.15K ﹤0.01% 1550
2024
Q1
$693K Buy
9,551
+175
+2% +$11.7K ﹤0.01% 1519
2023
Q4
$574K Buy
+9,376
New +$557K ﹤0.01% 1412

Other funds holding PBH

Pathstone Holdings's PBH Position: Q2 2026 in Review

Pathstone Holdings increased its Prestige Consumer Healthcare (PBH) stake by 9.2% in Q2 2026, buying an estimated $116K and bringing the position to 26,832 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1383.

Pathstone Holdings first reported a position in PBH in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.53M in Q1 2025. 318 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Pathstone Holdings held 26,832 shares of Prestige Consumer Healthcare worth $1.27M as of Q2 2026.
  • Pathstone Holdings bought 2,258 Prestige Consumer Healthcare shares in Q2 2026, an estimated $116K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1383 holding.
  • Pathstone Holdings first reported a position in Prestige Consumer Healthcare in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Prestige Consumer Healthcare position peaked at $2.53M in Q1 2025.
  • 318 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.